The PediaFlow Pediatric Ventricular Assist Device

Author(s):  
Brad E. Paden ◽  
Jingchun Wu ◽  
Myounggyu D. Noh ◽  
Dave Paden ◽  
Michael Ricci ◽  
...  

This paper describes a design process for a new pediatric ventricular assist device (VAD), the PediaFlow. The VAD is a magnetically levitated turbodynamic pump design for chronic support of infants and small children. The design entailed the consideration of multiple pump topologies, from which an axial mixed-flow configuration was chosen for further optimization via computation fluid dynamics. The magnetic design includes permanent-magnet (PM) passive bearings for radial support of the rotor, an actively controlled thrust actuator for axial support, and a brushless DC motor for rotation. These components are closely coupled both geometrically and magnetically, and were therefore optimized in parallel, using electromagnetic, rotordynamic and fluid models. Multiple design objectives were considered including efficiency, size, and margin between critical speed to operating speed. The former depends upon the radial and yaw stiffnesses of the PM bearings. Analytical expressions for the stiffnesses were derived and verified through FEA. A toroidally-wound motor was designed for high efficiency and minimal additional negative radial stiffness. The design process relies heavily on optimization at the component-level and system-level. The results of this preliminary design optimization yielded a pump design with an overall stability margin of 15 percent, based on a pressure rise of 100 mmHg at 0.5 lpm running at 16,000 RPM.

Author(s):  
Amit A. Pawale ◽  
Ariel Farkash ◽  
Dimosthenis Pandis ◽  
Anelechi C. Anyanwu

Driveline or device infection may complicate left ventricular assist device implants, and only curative option may be pump exchange. Replacement with similar device may be liable to reinfection, because pump configuration is such that the new device and driveline may partly lie within the pocket of the previous pump. One approach to overcome this is using a different pump design such that the new pump would lie in a different location from the old pump. We describe treatment of severe HeartMate II (Abbott, [St Jude Thoratec Corp], Pleasanton, CA USA) left ventricular assist device infection by minimally invasive exchange to an intrapericardial HVAD (HeartWare International, Inc, Framingham, MA USA) left ventricular assist device.


Author(s):  
J P Cassella ◽  
V Salih ◽  
T R Graham

Left ventricular assist systems are being developed for eventual long term or permanent implantation as an alternative to heart transplantation in patients unsuitable for or denied the transplant option. Evaluation of the effects of these devices upon normal physiology is required. A preliminary study was conducted to evaluate the morphology of aortic tissue from calves implanted with a pneumatic Left Ventricular Assist device-LVAD. Two 3 month old heifer calves (calf 1 and calf 2) were electively explanted after 128 days and 47 days respectively. Descending thoracic aortic tissue from both animals was removed immediately post mortem and placed into karnovsky’s fixative. The tissue was subsequently processed for transmission electron microscopy (TEM). Some aortic tissue was fixed in neutral buffered formalin and processed for routine light microscopy.


2011 ◽  
Vol 59 (S 01) ◽  
Author(s):  
M Barten ◽  
MT Dieterlen ◽  
S Klein ◽  
K Eberhardt ◽  
J Garbade ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document